Treatment outcome of children with HIV infection treated with highly active antiretroviral therapy (HAART)

Project no.: HIV-NAT 015

This is a long-term follow-up study of safety and efficacy of antiretroviral therapy for HIV positive children who have previously participated in HIV-NAT study protocols.


  1. Pattern and predictors of immunologic recovery in human immunodeficiency virus-infected children receiving non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy. Pediatr Infect Dis J. 2009 Jun;28(6):488-92.
  2. Immunologic and virologic failure after first-line highly active antiretroviral therapy in HIV-infected children. AIDS Res Ther. 2011 Oct 26;8:40.
  3. AIDS Care 2014;26(9):1144-9.